ERT Reports Rapid Growth with ERT Insights Cloud™

Share Article

Standard and Novel Implementations Fuel Growth of Data Analytics & Workflow Platform

News Image
"From analytics that can detect potential fraud to centralized rater surveillance, our customers are using ERT Insights Cloud in a paradigm shift toward data-driven processes for clinical trials management.”

ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced that it has experienced record growth in its ERT Insights Cloud solution – a suite of data analytics visualization, and workflow applications for use in pharmaceutical clinical development. Since being released in April 2015, ERT Insights Cloud has been adopted by more than 20 pharmaceutical, biotechnology and Contract Research Organizations (CROs) to improve the effectiveness of their clinical trials management and data surveillance strategies. New customer acquisitions represent mid-size biotech organizations to 5 of the world’s top 15 pharmaceutical companies, and 5 of the top 10 CROs.

Insights Cloud is helping customers view critical safety and efficacy endpoint data collected via ERT’s electronic Clinical Outcome Assessment (eCOA), Respiratory, and Cardiac Safety solutions within the context of their broader clinical trials data from central labs and EDC and IXR systems. By doing so, trial sponsors gain comprehensive insight into trial progress and risk indicators, which is critical for evaluating protocol compliance, site performance, and data quality issues. The platform’s decision-ready analytics drive workflow solutions that enable users to collaborate and ensure appropriate follow-up and intervention.

“We’ve been encouraged by the high level of interest in Insights Cloud from both existing and newly acquired customers,” said Amy Furlong, Executive Vice President, Cardiac Safety and eClinical Insights Solutions. “In addition to delivering intelligence across ERT endpoint solutions, we’ve seen an increase in customer collaborations to deploy our data analytics offering in innovative ways. From analytics that can detect potential fraud to centralized rater surveillance, our customers are using ERT Insights Cloud in a paradigm shift toward data-driven processes for clinical trials management.”

ERT Insights Cloud enables customers to aggregate and analyze data across clinical programs and drill into data trends and indicators. This capability has driven another trend: 60% of ERT’s customers that have deployed Insights Cloud have implemented the solution on a multi-study, clinical program or enterprise level to optimize and harmonize intelligence gathering.

ERT will demonstrate Insights Cloud in Booth #204 at the Society for Clinical Data Management’s (SCDM) Annual Meeting in Washington, DC beginning September 20, 2015. The meeting also features Insights Cloud Platform Manager Nick Neri as a speaker, delivering the session, “Endpoints to Insights: Integrating ‘External’ Data with the Broader eClinical Ecosystem.” For additional information, visit https://www.ert.com/scdm/.

For more information on Insights Cloud, join ERT’s September 15 webinar: “Analytics vs Reporting, Changing Your Clinical Research Paradigm through Actionable Insights.” For more information and to register, visit https://www.ert.com/upcoming-webinars/.

About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany. Join ERT on Facebook, LinkedIn, Twitter, and YouTube.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christine Tobin
ERT
+1 (412) 719-4568
Email >